No Data
No Data
Analysts' Top Healthcare Picks: Vir Biotechnology (VIR), Rocket Pharmaceuticals (RCKT)
Deep Dive Into Vir Biotechnology Stock: Analyst Perspectives (6 Ratings)
Across the recent three months, 6 analysts have shared their insights on Vir Biotechnology (NASDAQ:VIR), expressing a variety of opinions spanning from bullish to bearish.The table below provides a co
Express News | HC Wainwright & Co. Reiterates Buy on Vir Biotechnology, Maintains $110 Price Target
Analysts Just Shipped A Dazzling Upgrade To Their Vir Biotechnology, Inc. (NASDAQ:VIR) Estimates
Vir Biotechnology, Inc. (NASDAQ:VIR) shareholders will have a reason to smile today, with the analysts making substantial upgrades to this year's statutory forecasts. The analysts greatly increased
Earnings Call Summary | Vir Biotechnology(VIR.US) Q1 2024 Earnings Conference
The following is a summary of the Vir Biotechnology, Inc. (VIR) Q1 2024 Earnings Call Transcript:Financial Performance:VIR Biotechnology reported a Q1 2024 total revenue of $56.4 million, a decline fr
Vir Biotechnology Is Maintained at Neutral by JP Morgan
Vir Biotechnology Is Maintained at Neutral by JP Morgan
QianmengYuOP : not bad at GSK still sells somewhat and huge interest earnings. Regardless, free science. I bought more near support 7.8 (need to fight together with other bulls) will buy more if going down to support.